pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,347 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07356843: Palliative Care for People With HF

Sponsor: Indiana University. Phase: . Conditions: Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic

full page →ctgov ↗
›COMPLETEDphase readoutNCT07206485: Vibroacoustic Therap in Patients With Stroke

Sponsor: October 6 University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07074743: Evaluate the Feasibility and Effectiveness of a Community-based Care Bundle in Managing and Preventing Pressure Injuries

Sponsor: Singapore General Hospital. Phase: NA. Conditions: Pressure Injuries, Caregiver, Community Dwelling Older Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07543315: Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure

Sponsor: Tanta University. Phase: PHASE3. Conditions: Chronic Anal Fissure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07626515: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT00687115: Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE2. Conditions: Obesity, Diet Therapy, Weight Loss, Weight Gain, Nutrition Therapy

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04701515: Cardiovascular Manifestations of COVID-19

Sponsor: Methodist Health System. Phase: . Conditions: COVID-19

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06250335: Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: ICB-refractory Melanoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06956508: Prophylactic TBR on Phantom Limb Pain

Sponsor: OrthoCarolina Research Institute, Inc.. Phase: NA. Conditions: Phantom Limb Pain After Amputation

full page →ctgov ↗
›RECRUITINGphase readoutNCT05492825: IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Substance Use Disorders, Chronic Pain, Opioid Use Disorder, Back Pain Lower Back Chronic

full page →ctgov ↗
›COMPLETEDphase readoutNCT04365725: Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: COVID-19

full page →ctgov ↗
›COMPLETEDphase readoutNCT06818825: Nudging High Emergency Department Utilizers to Consider Non-emergent Healthcare Resources

Sponsor: Geisinger Clinic. Phase: NA. Conditions: Emergency Service, Hospital

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07423117: A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Sponsor: IntoCell, Inc. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Metastatic Solid Tumor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05165940: Facilitating Transition to Recommended PTSD Treatment

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD

full page →ctgov ↗
›RECRUITINGphase readoutNCT05279040: Trikafta Exercise Study in Cystic Fibrosis

Sponsor: University of British Columbia. Phase: . Conditions: Cystic Fibrosis, Lung Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT03016689: The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development

Sponsor: University of Minnesota. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05440617: Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Acute Ovarian Failure, Infertility, Early Menopause And Infertility In Females After Treatment For Childhood Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06680817: A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema

full page →ctgov ↗
›RECRUITINGphase readoutNCT05755217: Renal Ultrasound Response After Chocolate Consumption

Sponsor: Gregoire Wuerzner; MD. Phase: NA. Conditions: Chocolate Consumption

full page →ctgov ↗
›COMPLETEDphase readoutNCT04669912: COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management

Sponsor: Centre Hospitalier Sud Francilien. Phase: . Conditions: Type 1 Diabetes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05405712: Mobile Peer Support for OUD Recovery

Sponsor: Brown University. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07375719: Nuclear Abnormalities in Gingival Epithelial Cells in Relation to Periodontal Disease

Sponsor: Çankırı Karatekin University. Phase: . Conditions: Diabetes (DM), Periodontitis, Periodontitis (Stage 3), Micronuclei Count

full page →ctgov ↗
›COMPLETEDphase readoutNCT05033119: PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

Sponsor: Ulla Schierup Nielsen. Phase: . Conditions: Hyperprolactinemia, Puberty Disorders, Metabolic Syndrome, Growth Disorders, Antipsychotics and Neuroleptics Toxicity

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07367919: The Effect of a Digital Literacy Program on Problematic Internet Use, Emotion Regulation, and Loneliness in Adolescents: A Randomized Controlled Trial

Sponsor: Ataturk University. Phase: NA. Conditions: Healthy Adolescents

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05238519: Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

Sponsor: Essentia Health. Phase: PHASE3. Conditions: Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07597928: A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy Adults, Healthy

full page →ctgov ↗
›WITHDRAWNphase readoutNCT03974828: Telemedicine Notifications With Machine Learning for Postoperative Care

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Surgery--Complications, Perioperative/Postoperative Complications, Acute Kidney Injury, Hospital Mortality

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07027267: Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

Sponsor: Spirair, Inc. Phase: NA. Conditions: Sinus Endoscopic Surgery, Turbinate

full page →ctgov ↗
›RECRUITINGphase readoutNCT06998407: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Sponsor: Avenzo Therapeutics, Inc.. Phase: PHASE1. Conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02177292: High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06930092: RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Ischemic Cardiomyopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04898634: A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Prostatic Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT07256444: Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07514234: Optimal Allogeneic PRP Concentration for Oocyte In Vitro Maturation in Women With PCOS

Sponsor: Gadjah Mada University. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07454109: The Effect of a Stress Coping Training Program for University Students

Sponsor: Hacettepe University. Phase: NA. Conditions: Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT07585799: Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

Sponsor: Óscar Cano Pérez. Phase: NA. Conditions: Bradycardia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07580963: Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Ureteral Stent-Related Symptom

full page →ctgov ↗
›RECRUITINGphase readoutNCT07527793: Monitoring Changes in Blood Circulating Metabolites Using Minimally Invasive Techniques

Sponsor: Örebro University, Sweden. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT06275893: IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

Sponsor: Implicit Bioscience. Phase: PHASE1. Conditions: Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Left Ventricular Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy 1, Arrhythmogenic Cardiomyopathy, ACM, ARVC, PKP2

full page →ctgov ↗
›RECRUITINGphase readoutNCT06670521: Corticosteroids for Post-Extubation Dysphagia

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Dysphagia, Laryngeal Edema

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06716021: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Sponsor: Milestone Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Atrial Fibrillation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07333521: Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Isolated Non-acquired Growth Hormone Deficiency

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07469514: Coaching, Learning, Empowerment in Cerebral Palsy - a 6-Week Integrated PT/OT Caregiver "Primer" Bootcamp for Infants Diagnosed With or at High Risk for Cerebral Palsy

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Infantile, Infant

full page →ctgov ↗
›COMPLETEDphase readoutNCT04747314: Treating Negative Affect in Low Back Pain Patients

Sponsor: Ajay Wasan, MD, Msc. Phase: PHASE2. Conditions: Chronic Low Back Pain, Negative Affectivity

full page →ctgov ↗
›RECRUITINGphase readoutNCT05125016: A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06157216: Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Stage II-III Gastric Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04276116: Effectiveness of the Evaluation and Communication of "Pulmonary Age" as Help for Smoking Cessation

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Smoking Cessation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06724484: Post-operative Anxiety and Depression Among Older Adults Who Undergo Surgery for Fragility Fractures

Sponsor: University of Southampton. Phase: . Conditions: Fractures in the Elderly

full page →ctgov ↗
›RECRUITINGphase readoutNCT05858684: Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients

Sponsor: RenJi Hospital. Phase: EARLY_PHASE1. Conditions: CAR-T Cell Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06639984: Psyllium in Pediatric IBS

Sponsor: Dr Bruno Chumpitazi, M.D.. Phase: PHASE2. Conditions: Irritable Bowel Syndrome

full page →ctgov ↗
← prev
page 50 of 107
next →